Successful treatment with adalimumab in infliximab-resistant Crohn's disease

被引：20
|
作者：
Barthel, HR
Gille, T
Halbsguth, A
Kramer, M
机构：
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2005年 / 20卷 / 09期
关键词：
D O I：
10.1111/j.1440-1746.2005.03848.x
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1464 / 1465
页数：2
相关论文
共 50 条
  • [1] Successful treatment with adalimumab in infliximab-resistant Crohn's disease
    Barthel, HR
    Gille, T
    Halbsguth, A
    Kramer, M
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (10): : S121 - S121
  • [2] Successful treatment of therapy-resistant metastatic Crohn's disease with infliximab
    Rispo, A
    Lembo, G
    Insabato, L
    Cozzolino, A
    Pesce, G
    Castiglione, F
    BRITISH JOURNAL OF DERMATOLOGY, 2004, 150 (05) : 1045 - 1046
  • [3] INFLIXIMAB VERSUS ADALIMUMAB IN THE TREATMENT OF PERIANAL CROHN'S DISEASE
    Maas, Laura A.
    Limketkai, Berkeley N.
    Lazarev, Mark
    Melia, Joanna
    Selaru, Florin M.
    Parian, Alyssa M.
    GASTROENTEROLOGY, 2022, 162 (07) : S817 - S817
  • [4] Monocytes from infliximab-resistant patients with Crohn’s disease exhibit a disordered cytokine profile
    Federica Gaiani
    Bianca Maria Rotoli
    Francesca Ferrari
    Amelia Barilli
    Rossana Visigalli
    Maria Clotilde Carra
    Gian Luigi de’Angelis
    Nicola de’Angelis
    Valeria Dall’Asta
    Scientific Reports, 10
  • [5] Monocytes from infliximab-resistant patients with Crohn's disease exhibit a disordered cytokine profile
    Gaiani, Federica
    Rotoli, Bianca Maria
    Ferrari, Francesca
    Barilli, Amelia
    Visigalli, Rossana
    Carra, Maria Clotilde
    de'Angelis, Gian Luigi
    de'Angelis, Nicola
    Dall'Asta, Valeria
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [6] Onset of Severe Perianal Disease in Crohn's Disease Under Treatment with Infliximab: Successful Treatment with Adalimumab and Setons Drainage
    Tursi, Antonio
    Papa, Alfredo
    Maiorano, Michele
    INFLAMMATORY BOWEL DISEASES, 2011, 17 (02) : 676 - 678
  • [7] Commentary: infliximab or adalimumab in Crohn's disease?
    Sprakes, M. B.
    Hamlin, P. J.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 36 (04) : 398 - 398
  • [8] Infliximab vs Adalimumab for Crohn's Disease
    Dhillon, Angad S.
    Harris, Adam W.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2015, 13 (01) : 210 - 210
  • [9] Adalimumab or infliximab as monotherapy, or in combination with an immunomodulator, in the treatment of Crohn's disease
    Cosnes, J.
    Sokol, H.
    Bourrier, A.
    Nion-Larmurier, I.
    Wisniewski, A.
    Landman, C.
    Marteau, P.
    Beaugerie, L.
    Perez, K.
    Seksik, P.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 44 (10) : 1102 - 1113
  • [10] Successful treatment of psychosis with infliximab in a patient with Crohn's disease
    Reimer, Jens
    Fink, Torsten
    Schaefer, Ingo
    Otte, Christian
    Blaeker, Michael
    SCHIZOPHRENIA RESEARCH, 2009, 109 (1-3) : 194 - 195
12345